Claims for Patent: 8,778,308

Summary for Patent: 8,778,308

Title:	Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
Abstract:	The disclosed invention relates to the observation that nestin expression is a marker for endothelial cell proliferation. Nestin expression is particularly useful as a marker for angiogenesis, particularly for tumor-related angiogenesis. Specifically, nestin serves as an excellent endothelium marker for brain tumors such as gliomas, hemangioblastomas, Schwannomas, medulloblastomas, and meningiomas. Accordingly, the disclosed invention relates to the use of this marker as a basis to model angiogenic activity.
Inventor(s):	Amoh; Yasuyuki (San Diego, CA), Li; Lingna (San Diego, CA), Yang; Meng (San Diego, CA), Jiang; Ping (San Diego, CA)
Assignee:
Application Number:	10/977,219
Patent Claims:	1. A method of monitoring blood vessel development in vivo, comprising: providing a mouse hair follicle stem cell isolated from vibrissa follicles, wherein the stem cell comprises an expression cassette encoding a first fluorescent protein (FP) under control of a hair follicle tissue specific promoter and the nestin second-intron enhancer and wherein the stem cell is a nestin expressing cell; growing the stem cell in an allogeneic immunodeficient mouse host; and visualizing nascent blood vessel development produced by the stem cell following growth of the stem cell, whereby blood vessel development is monitored. 2. The method of claim 1, wherein the fluorescent protein is selected from the group consisting of green fluorescent protein (GFP), red fluorescent protein (RFP), blue fluorescent protein (BFP) and yellow fluorescent protein (YFP). 3. The method of claim 1, wherein the host is a nude mouse. 4. The method of claim 1, wherein the stem cell an angiogenic stem cell. 5. A method of screening for a modulator of nascent blood vessel development in vivo, comprising: providing a mouse hair follicle stem cell isolated from vibrissa follicles, wherein the stem cell comprises an expression cassette encoding a first fluorescent protein (FP) under control of a hair follicle tissue specific promoter and the nestin second-intron enhancer and wherein the stem cell is a nestin expressing cell; growing the stem cell in an allogeneic immunodeficient mouse host in the presence of an exogenously added angiogenesis modulating agent; and visualizing nascent blood vessel development produced by the stem cell growth of the stem cell. 6. The method of claim 5, wherein the fluorescent protein is selected from the group consisting of green fluorescent protein (GFP), red fluorescent protein (RFP), blue fluorescent protein (BFP) and yellow fluorescent protein (YFP). 7. The method of claim 5, wherein the host is a nude mouse. 8. The method of claim 5, wherein the stem cell is an angiogenic stem cell. 9. The method of claim 1, wherein the stem cell further comprises a second FP protein under control of the nestin second-intron enhancer, wherein the first FP protein is different from the second FP protein. 10. The method of claim 8, wherein the host organism comprises a second FP protein under control of the nestin second-intron enhancer, wherein the first FP protein is different from the second FP protein.

Details for Patent 8,778,308

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-02-26